Shefali Agarwal's Net Worth

$173 Thousand

Estimate Recalculated Apr 30, 2024 05:30PM EST

Who is Shefali Agarwal?

Shefali Agarwal does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Gritstone bio, Inc., FATE THERAPEUTICS INC, and Epizyme, Inc..

SEC CIK

Shefali Agarwal's CIK is 0001746830

Past Insider Trading and Trends

2019 was Shefali Agarwal's most active year for acquiring shares with 8 total transactions. Shefali Agarwal's most active month to acquire stocks was the month of May. 2022 was Shefali Agarwal's most active year for disposing of shares, totalling 12 transactions. Shefali Agarwal's most active month to dispose stocks was the month of July. 2022 saw Shefali Agarwal paying a total of $697,952.21 for 1,041,874 shares, this is the most they've acquired in one year. In 2022 Shefali Agarwal cashed out on 1,167,960 shares for a total of $566,598.02, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Gritstone bio, Inc. (GRTS) Snapshot price: $2.14

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
Jun 1
Form 3
—
0
—
—
0
No matching records found

FATE THERAPEUTICS INC (FATE) Snapshot price: $5.65

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 6
Form 4
+470.11%
8.65K
—
—
10.49K
Jun 9
Form 4
-31.37%
-841.00
$21.89
-$18,409.49
1.84K
Jun 7
Form 4/A
—
0
—
—
2.68K
Jun 3
Form 4
-30.10%
-807.00
$22.80
-$18,399.60
1.87K
Jun 3
Form 4
∞
2.68K
—
—
2.68K
Jun 2
Form 4
—
0
—
—
0
May 1
Form 4
—
0
—
—
0
Jul 15
Form 3
—
0
—
—
0
No matching records found

Epizyme, Inc. No price found

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-286.54K
—
—
0
Aug 12
Form 4
+79.92%
126.85K
$1.39
$176,315.94
285.56K
Aug 9
Form 4
+1.49%
2.33K
$1.27
$2,952.21
158.72K
Feb 28 - Mar 17
Form 4
-0.67%
-1.06K
$1.50
-$1,587.00
156.38K
Scheduled
Feb 7
Form 4
-1.65%
-2.64K
$1.37
-$3,615.43
157.44K
Scheduled
Feb 2
Form 4
-1.79%
-2.92K
$2.02
-$5,902.44
160.08K
Scheduled
Jan 26
Form 4
-1.08%
-1.78K
$2.93
-$5,215.40
163K
Scheduled
Dec 6
Form 4
+56.70%
59.17K
—
—
163.51K
Aug 16
Form 4
-0.92%
-969.00
$11.21
-$10,862.49
104.34K
Scheduled
Feb 4
Form 4
+39.07%
29.58K
—
—
105.31K
Feb 1
Form 4
-3.65%
-2.87K
$11.41
-$32,769.52
75.73K
Scheduled
Jan 25
Form 4
-3.21%
-2.52K
$13.54
-$34,147.88
76.09K
Scheduled
Dec 3
Form 4
+5.64%
4.2K
$16.15
-$29,150.75
78.61K
Scheduled
Jun 25 - Jun 26
Form 4/A
+5.68%
4K
—
—
74.42K
Mar 24
Form 4
+0.46%
332
$15.28
-$18,993.04
71.99K
Scheduled
Mar 24 - Mar 25
Form 4
+21.86%
12.86K
—
—
71.66K
Feb 3
Form 4
+0.90%
527
$22.17
-$99,168.72
58.8K
Scheduled
Jan 23 - Jan 27
Form 4/A
+63.24%
22.58K
—
—
58.28K
Dec 2
Form 4
+63.24%
22.58K
—
—
58.28K
Dec 2
Form 4
-3.24%
-1.20K
$11.97
-$14,304.15
35.7K
Scheduled
Jun 14
Form 4
+12.16%
4K
—
—
36.89K
Jun 12
Form 4
∞
32.89K
—
—
32.89K
Jan 24
Form 4
—
0
—
—
0
Jul 23
Form 3
—
0
—
—
0
No matching records found